Assert-IQ vs cV8 Diagnostic Ultrasound System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Assert-IQ

by Abbott

cV8 Diagnostic Ultrasound System

by Samsung Healthcare

AI Verdict

Assert-IQ is an insertable cardiac monitor focused on long-term, continuous detection and management of heart rhythm disorders. In contrast, the cV8 Diagnostic Ultrasound System is a versatile imaging platform that uses AI to enhance real-time diagnostic ultrasound across multiple specialties, including specific fetal heart assessments. While both leverage AI in cardiology, their core technologies and clinical applications are distinct, with one focusing on chronic monitoring and the other on acute diagnostic imaging.

Choose Assert-IQ if…

Choose Assert-IQ if your primary need is long-term, continuous monitoring for patients with suspected or intermittent heart rhythm disorders that may not be captured by short-term diagnostic methods. This system is ideal for detecting subtle arrhythmias over an extended period, providing remote monitoring capabilities and proactive alerts to clinicians.

View Assert-IQ →

Choose cV8 Diagnostic Ultrasound System if…

Choose the cV8 Diagnostic Ultrasound System if your practice requires a versatile, high-performance imaging solution for real-time diagnosis across multiple specialties. This system excels in providing superior image clarity and AI-based assistance for precise measurements and detailed visualization, enhancing diagnostic confidence in areas like neurology, obstetrics, gynecology, and general radiology.

View cV8 Diagnostic Ultrasound System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Assert-IQ	cV8 Diagnostic Ultrasound System
Pricing	Unknown	Varies
Deployment	Subcutaneously implanted device with mobile app connectivity	On-premise (hospital environments and outpatient diagnostic clinics)
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

cV8 Diagnostic Ultrasound System

Tool B, the cV8 Diagnostic Ultrasound System, emphasizes direct clinician usability with an ergonomic design, a large LED monitor, and a high-sensitivity touch panel. Features like EzExam+ and EzPrep are specifically designed to streamline examination protocols and enhance workflow efficiency during real-time operation.

Clinical Value

cV8 Diagnostic Ultrasound System

While Tool A provides valuable long-term cardiac monitoring, Tool B offers superior image quality through Crystal Architecture and a comprehensive suite of AI-based diagnostic assistance tools (e.g., NerveTrack, HeartAssist) across diverse medical specialties. These features directly enhance real-time diagnostic confidence and provide broader clinical utility.

Pricing & Value

Tie

Both tools have opaque pricing models, requiring direct contact with the vendor for institutional or enterprise pricing. Neither offers a free trial, making it impossible to compare their value propositions without specific cost information.

Enterprise Readiness

Assert-IQ

Both tools are FDA cleared and HIPAA compliant. However, Tool A's hybrid deployment, secure cloud-based data platform, and remote monitoring capabilities, explicitly targeting large health systems, suggest a more robust and scalable architecture for enterprise-wide data management and integration.

Innovation

cV8 Diagnostic Ultrasound System

Tool B demonstrates greater innovation with its advanced Crystal Architecture for imaging and a comprehensive array of AI-based Intelligent Assist solutions that integrate directly into the diagnostic workflow across multiple specialties. This breadth of AI-powered features, combined with cutting-edge imaging technologies, represents a more significant innovative leap.

Support & Docs

Tie

The provided structured facts do not contain specific information regarding support or documentation for either tool. While both companies are major medical device manufacturers expected to offer robust support, there is no basis to differentiate them in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Assert-IQ	cV8 Diagnostic Ultrasound System
Product Name	Assert-IQ	cV8 Diagnostic Ultrasound System
Description	The Assert-IQu2122 Insertable Cardiac Monitor (ICM) system provides long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders.	The Samsung Medison cV8 Diagnostic Ultrasound System is a premium, mobile, and software-controlled ultrasound system featuring advanced Crystal Architectureu2122 for superior image quality and AI-based diagnostic assistance tools like NerveTracku2122 and HeartAssistu2122 to enhance clinical confidence and workflow efficiency across diverse medical specialties.
Company	Abbott Medical	Samsung Medison Co.
Categories	Cardiology AI, Clinical Decision Support & Reference	Cardiology AI, Radiology & Imaging AI
Specialties	Cardiology, Internal Medicine	Neurology, Obstetrics & Gynecology, Radiology
Key Features (Examples)	Long-term continuous cardiac monitoring (up to 6 years), Advanced arrhythmia detection algorithms, Remote monitoring capabilities	Crystal Architectureu2122 for superior image clarity, AI-based Intelligent Assist solutions (e.g., NerveTracku2122, HeartAssistu2122)

Videos

Demos, reviews, and walkthroughs featuring Assert-IQ and cV8 Diagnostic Ultrasound System.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for patient diagnosis and management, given their distinct functionalities?

Assert-IQ provides long-term, continuous, remote cardiac monitoring with proactive alerts for diagnosing and managing heart rhythm disorders, and offers remote programmability to adjust settings without in-clinic visits. The cV8 system offers real-time, mobile diagnostic ultrasound imaging with AI assistance to enhance clinical confidence and workflow efficiency across diverse medical specialties, featuring streamlined examination protocols.

What level of integration can be expected with our existing Electronic Health Record (EHR) systems for each tool, particularly regarding data flow and accessibility?

Assert-IQ utilizes a secure cloud-based data platform for remote monitoring data, transmitting results to a clinic's portal, though direct API integration is not available. For the cV8 system, as an on-premise hardware ultrasound, it would typically support DICOM for image transfer to PACS and potentially EHRs, but deeper integration for structured reporting directly into EHRs is not explicitly detailed.

How do the AI capabilities of each tool specifically contribute to diagnostic accuracy and sensitivity in their respective clinical applications?

Assert-IQ employs advanced AI algorithms that reduce false positives for AF and Pause episodes while maintaining high sensitivity, transforming device detections into a more curated, decision-ready view. The cV8 system leverages AI-based Intelligent Assist solutions like NerveTracku2122 and HeartAssistu2122 for superior image quality and to enhance diagnostic confidence in real-time imaging across various specialties.

Given our multi-specialty practice, how does each tool's design and features cater to specific medical specialties, and what is its versatility across different departments?

Assert-IQ is primarily designed for Cardiology and Internal Medicine, focusing on long-term monitoring for patients with suspected heart rhythm disorders or those susceptible to developing AF. In contrast, the cV8 system is highly versatile, catering to Neurology, Obstetrics & Gynecology, and Radiology, and includes Cardiology AI features for fetal heart diagnosis.

What is the expected learning curve for physicians and staff to effectively utilize each system, particularly concerning their unique features and AI assistance?

Assert-IQ involves a minimally invasive insertion procedure and remote monitoring setup, with patient activators for symptom logging and remote programming capabilities. The cV8 system features an ergonomic design, a high-sensitivity touch panel, and streamlined examination protocols like EzExam+u2122 and EzPrepu2122 to enhance workflow efficiency and ease of use, though advanced ultrasound systems can have a learning curve for image acquisition.